VAERS Explorer
Back to explore

Report #2847818

Received Jun 30, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
30 yrs
State
CA
Recovered
Not recovered
Vaccinated
Jun 24, 2025
Onset
Jun 25, 2025
Days to onset
1
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (MODERNA))MODERNAUNK3046734IM

Symptoms (6)

Back painChest painChillsHeadacheNauseaPain

Symptom narrative

chest pain; upper back pain; sore body; headache; chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pain), BACK PAIN (upper back pain), PAIN (sore body), HEADACHE (headache) and CHILLS (chills) in a 30-year-old female patient who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. 3046734) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 24-Jun-2025, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) .5 milliliter. On 25-Jun-2025, the patient experienced CHEST PAIN (chest pain), BACK PAIN (upper back pain), PAIN (sore body), HEADACHE (headache), CHILLS (chills) and NAUSEA (nausea). At the time of the report, CHEST PAIN (chest pain), BACK PAIN (upper back pain), PAIN (sore body), HEADACHE (headache), CHILLS (chills) and NAUSEA (nausea) had not resolved. The action taken with mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Intramuscular use) was unknown. No concomitant medication was reported. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported.